Foxp3 + T cells in peripheral blood of renal transplant recipients and clinical correlations

Nephrology

Volumn 17, Issue 4, 2012, Pages 415-422

  Lin, Wen X ^a   Christiansen, Dale ^a   Fu, Lu L ^c   Roberts, Matthew A ^b   Sandrin, Mauro S ^a   Ierino, Francesco L ^a,b  

^a Department of Surgery ^*  (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

Author keywords

estimated GFR; forkhead box P3; regulatory T cell; transplantation

Indexed keywords

TRANSCRIPTION FACTOR FOXP3;

ADULT; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CELL POPULATION; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; GLOMERULUS FILTRATION RATE; GRAFT RECIPIENT; GRAFT REJECTION; GROUPS BY AGE; HOSPITAL ADMISSION; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SKIN CANCER;

ADULT; AGED; BIOLOGICAL MARKERS; FEMALE; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; GLOMERULAR FILTRATION RATE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOPHENOTYPING; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; LINEAR MODELS; MALE; MIDDLE AGED; MONITORING, IMMUNOLOGIC; MULTIVARIATE ANALYSIS; NEOPLASMS; RISK ASSESSMENT; RISK FACTORS; T-LYMPHOCYTES, REGULATORY; TIME FACTORS; TREATMENT OUTCOME; VICTORIA; WAITING LISTS;

EID: 84860173467     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2012.01578.x     Document Type: Article

References (35)

1. Hall BM, Jelbart ME, Dorsch SE,. Suppressor T cells in rats with prolonged cardiac allograft survival after treatment with cyclosporine. Transplantation 1984; 37: 595-600. (Pubitemid 14083115)
2. Dorsch S, Roser R,. Recirculating, suppressor T cells in transplantation tolerance. J. Exp. Med. 1977; 145: 1144-57. (Pubitemid 8105360)
3. Kilshaw PJ, Brent L, Pinto M,. Suppressor T cells in mice made unresponsive to skin allografts. Nature 1975; 255: 489-91.
4. Sakaguchi S, Powrie F,. Emerging challenges in regulatory T cell function and biology. Science 2007; 317: 627-9. (Pubitemid 47229955)
5. Hori S, Nomura T, Sakaguchi S,. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003; 299: 1057-61. (Pubitemid 36222930)
6. Baecher-Allan C, Viglietta V, Hafler DA,. Human CD4+CD25+ regulatory T cells. Semin. Immunol. 2004; 16: 89-98.
7. Hall BM, Pearce NW, Gurley KE, Dorsch SE,. Specific unresponsiveness in rats with prolonged cardiac allograft survival after treatment with cyclosporine. III. Further characterization of the CD4+ suppressor cell and its mechanisms of action. J. Exp. Med. 1990; 171: 141-57. (Pubitemid 20040605)
8. Wan YY, Flavell RA,. Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression. Nature 2007; 445: 766-70. (Pubitemid 46279706)
9. Brown K, Wong W,. Diagnostic value of regulatory T cells: A new facet of a much studied cell population. Transplantation 2008; 86: 1485-91.
10. Fontenot JD, Gavin MA, Rudensky AY,. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat. Immunol. 2003; 4: 330-36. (Pubitemid 36432314)
11. Yagi H, Nomura T, Nakamura K, et al,. Crucial role of FOXP3 in the development and function of human CD25+CD4+ regulatory T cells. Int. Immunol. 2004; 16: 1643-56.
12. Feuerer M, Hill JA, Mathis D, Benoist C,. Foxp3+ regulatory T cells: Differentiation, specification, subphenotypes. Nat. Immunol. 2009; 10: 689-95.
13. Mitchell P, Afzali B, Lombardi G, Lechler RI,. The T helper 17-regulatory T cell axis in transplant rejection and tolerance. Curr Opin Organ Transplant 2009; 14: 326-31.
14. Dijke IE, Caliskan K, Korevaar SS, et al,. FOXP3 mRNA expression analysis in the peripheral blood and allograft of heart transplant patients. Transpl. Immunol. 2008; 18: 250-54. (Pubitemid 350151856)
15. Dijke IE, Caliskan K, Korevaar SS, Balk AH, Zondervan PE, Maat AP,. Acute rejection is associated with high FOXP3 mRNA expression levels in the graft, but not in the peripheral blood, of heart transplant recipients. J. Heart Lung Transplant. 2007; 26: S72.
16. Dijke IE, Velthuis JH, Caliskan K, et al,. Intragraft FOXP3 mRNA expression reflects antidonor immune reactivity in cardiac allograft patients. Transplantation 2007; 83: 1477-84. (Pubitemid 46934071)
17. Muthukumar T, Dadhania D, Ding R, et al,. Messenger RNA for FOXP3 in the urine of renal-allograft recipients. N. Engl. J. Med. 2005; 353: 2342-51. (Pubitemid 41713746)
18. Yapici U, Bemelman FJ, Scheepstra CG, et al,. Intragraft FOXP3 protein or mRNA during acute renal allograft rejection correlates with inflammation, fibrosis, and poor renal outcome. Transplantation 2009; 87: 1377-80.
19. Bunnag S, Allanach K, Jhangri GS, et al,. FOXP3 expression in human kidney transplant biopsies is associated with rejection and time post transplant but not with favorable outcomes. Am. J. Transplant. 2008; 8: 1423-33. (Pubitemid 351989494)
20. Zuber J, Brodin-Sartorius A, Lapidus N, et al,. FOXP3-enriched infiltrates associated with better outcome in renal allografts with inflamed fibrosis. Nephrol. Dial. Transplant. 2009; 24: 3847-54.
21. Fondi C, Nozzoli C, Benemei S, et al,. Increase in FOXP3+ regulatory T cells in GVHD skin biopsies is associated with lower disease severity and treatment response. Biol Blood Marrow Transplant 2009; 15: 938-47.
22. Yoshizawa A, Ito A, Li Y, et al,. The roles of CD25+CD4+ regulatory T cells in operational tolerance after living donor liver transplantation. Transplant. Proc. 2005; 37: 37-9. (Pubitemid 40459681)
23. Li Y, Koshiba T, Yoshizawa A, et al,. Analyses of peripheral blood mononuclear cells in operational tolerance after pediatric living donor liver transplantation. Am. J. Transplant. 2004; 4: 2118-25. (Pubitemid 39611642)
24. Mathew TH,. Chronic kidney disease and automatic reporting of estimated glomerular filtration rate: A position statement. Med. J. Aust. 2005; 183: 138-41. (Pubitemid 41087045)
25. Cockcroft DW, Gault MH,. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31-41.
26. Descamps-Latscha B, Chatenoud L,. T cells and B cells in chronic renal failure. Semin. Nephrol. 1996; 16: 183-91. (Pubitemid 26151233)
27. Girndt M, Sester U, Sester M, Kaul H, Kohler H,. Impaired cellular immune function in patients with end-stage renal failure. Nephrol. Dial. Transplant. 1999; 14: 2807-10.
28. Hendrikx TK, van Gurp EA, Sewgobind VD, et al,. Generation of donor-specific regulatory T-cell function in kidney transplant patients. Transplantation 2009; 87: 376-83.
29. Poge U, Gerhardt T, Palmedo H, Klehr HU, Sauerbruch T, Woitas RP,. MDRD equations for estimation of GFR in renal transplant recipients. Am. J. Transplant. 2005; 5: 1306-11. (Pubitemid 40839418)
30. Poge U, Gerhardt T, Stoffel-Wagner B, et al,. Can modifications of the MDRD formula improve the estimation of glomerular filtration rate in renal allograft recipients? Nephrol. Dial. Transplant. 2007; 22: 3610-15. (Pubitemid 350212479)
31. White CA, Huang D, Akbari A, Garland J, Knoll GA,. Performance of creatinine-based estimates of GFR in kidney transplant recipients: A systematic review. Am. J. Kidney Dis. 2008; 51: 1005-15. (Pubitemid 351697570)
32. Kreijveld E, Koenen HJ, van Cranenbroek B, van Rijssen E, Joosten I, Hilbrands LB,. Immunological monitoring of renal transplant recipients to predict acute allograft rejection following the discontinuation of tacrolimus. PLoS ONE 2008; 3: e2711.
33. Mittal SK, Sharma RK, Gupta A, Naik S,. Increased interleukin-10 production without expansion of CD4+CD25+ T-regulatory cells in early stable renal transplant patients on calcineurin inhibitors. Transplantation 2009; 88: 435-41.
34. Webster AC, Wong G, Craig JC, Chapman JR,. Managing cancer risk and decision making after kidney transplantation. Am. J. Transplant. 2008; 8: 2185-91.
35. Carroll RP, Segundo DS, Hollowood K, et al,. Immune phenotype predicts risk for posttransplantation squamous cell carcinoma. J. Am. Soc. Nephrol. 2010; 21: 713-22.